Biocon Q4
-
{
- All
- News
-
Biocon Net Profit Jumps 105% To Rs 254 Crore In March Quarter
Biocon Q4 Results: Biocon's consolidated revenue increased 26 per cent in the fourth quarter of the fiscal 2020-21 to Rs 2,044 crore, compared to Rs 1,621 crore in the corresponding quarter last year.
-
Biocon Net Profit Jumps 105% To Rs 254 Crore In March Quarter
Biocon Q4 Results: Biocon's consolidated revenue increased 26 per cent in the fourth quarter of the fiscal 2020-21 to Rs 2,044 crore, compared to Rs 1,621 crore in the corresponding quarter last year.
-
Q4 Resuts: Biocon’s Profit Meets Estimates Buoyed By Strong Growth In Biologics Unit
Biocon’s branded formulations business, however, failed to deliver this time around.
-
Biocon’s Net Profit Rises For The First Time In Five Quarters
Revenues during the March quarter grew 25.6 percent to Rs 1,169.5 crore.
-
Biocon Profit Soars 79% To Rs 361 Crore In Q4
Biocon's EBITDA or operating profit jumped 18 per cent to Rs 238 crore compared to Rs 202 crore, while EBITDA margin remained stable at 24 per cent.
-
Biocon Jumps Over 3% as Q4 Net Meets Estimates
The pharmaceutical company said that its net profit for the fourth quarter jumped 120 per cent to Rs 201 crore from Rs 91 crore in the same quarter last year on revenue of Rs 830 crore.
-
Biocon Q4 net dips 54% at Rs 113 crore
Net sales of the company rose to Rs 722.59 crore for the fourth quarter as against Rs 630.12 crore for the same period a year ago, Biocon Ltd said in a statement.
.jpg?downsize=260:146 "Q4 Resuts: Biocon’s Profit Meets Estimates Buoyed By Strong Growth In Biologics Unit")
-
Biocon Net Profit Jumps 105% To Rs 254 Crore In March Quarter
Biocon Q4 Results: Biocon's consolidated revenue increased 26 per cent in the fourth quarter of the fiscal 2020-21 to Rs 2,044 crore, compared to Rs 1,621 crore in the corresponding quarter last year.
-
Biocon Net Profit Jumps 105% To Rs 254 Crore In March Quarter
Biocon Q4 Results: Biocon's consolidated revenue increased 26 per cent in the fourth quarter of the fiscal 2020-21 to Rs 2,044 crore, compared to Rs 1,621 crore in the corresponding quarter last year.
-
Q4 Resuts: Biocon’s Profit Meets Estimates Buoyed By Strong Growth In Biologics Unit
Biocon’s branded formulations business, however, failed to deliver this time around.
-
Biocon’s Net Profit Rises For The First Time In Five Quarters
Revenues during the March quarter grew 25.6 percent to Rs 1,169.5 crore.
-
Biocon Profit Soars 79% To Rs 361 Crore In Q4
Biocon's EBITDA or operating profit jumped 18 per cent to Rs 238 crore compared to Rs 202 crore, while EBITDA margin remained stable at 24 per cent.
-
Biocon Jumps Over 3% as Q4 Net Meets Estimates
The pharmaceutical company said that its net profit for the fourth quarter jumped 120 per cent to Rs 201 crore from Rs 91 crore in the same quarter last year on revenue of Rs 830 crore.
-
Biocon Q4 net dips 54% at Rs 113 crore
Net sales of the company rose to Rs 722.59 crore for the fourth quarter as against Rs 630.12 crore for the same period a year ago, Biocon Ltd said in a statement.
